UB Paderborn / Katalog / Suche / in CDI

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

The Lancet infectious diseases, 2012-07, Vol.12 (7), p.531-537

2012

Link zum Volltext

Verfügbarkeit prüfen

Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection

PLoS pathogens, 2014-01, Vol.10 (1), p.e1003853-e1003853

2014

Link zum Volltext

Verfügbarkeit prüfen

The US Military Commitment to Vaccine Development: A Century of Successes and Challenges

Frontiers in immunology, 2018-06, Vol.9, p.1397-1397

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

PloS one, 2010-11, Vol.5 (11), p.e13983

2010

Link zum Volltext

Verfügbarkeit prüfen

Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression

PloS one, 2015-12, Vol.10 (12), p.e0144767-e0144767

2015

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2190690-2190690

2023

Link zum Volltext

Verfügbarkeit prüfen

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

Frontiers in immunology, 2024, Vol.15, p.1285278-1285278

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities

Malaria journal, 2018-05, Vol.17 (1), p.214-214, Article 214

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost

Journal of acquired immune deficiency syndromes (1999), 2007-09, Vol.46 (1), p.48

2007

Link zum Volltext

Verfügbarkeit prüfen

Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection

Pathogens & immunity, 2017, Vol.2 (1), p.66-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

AIDS (London), 2012-07, Vol.26 (11), p.1452-1452

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population

Journal of acquired immune deficiency syndromes (1999), 2008-10, Vol.49 (2), p.151

2008

Link zum Volltext

Verfügbarkeit prüfen

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

AIDS (London), 2012-01, Vol.26 (1), p.1-9

2012

Link zum Volltext

Verfügbarkeit prüfen

Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors

AIDS research and human retroviruses, 2012-12, Vol.28 (12), p.1703

2012

Link zum Volltext

Verfügbarkeit prüfen

Lymphoproliferative responses to HIV-1 Gag p24 antigen and mitogens in HIV-1 subtype CRF01_AE infected Thai patients and HIV-1 seronegative donors

Retrovirology, 2006-12, Vol.3 (S1), p.P13-P13, Article P13

2006

Link zum Volltext

Verfügbarkeit prüfen

Changes in HIV prevalence among young thai men as defined by hepatitis C co-infection as a marker for mode of transmission

AIDS (London), 2004-11, Vol.18 (17), p.2339-2341

2004

Link zum Volltext

Verfügbarkeit prüfen

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV

PloS one, 2015-11, Vol.10 (11), p.e0142600-e0142600

2015

Link zum Volltext

Verfügbarkeit prüfen

Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants

Malaria journal, 2016-05, Vol.15 (1), p.280-280, Article 280

2016

Link zum Volltext

Verfügbarkeit prüfen

Pseudohypacusis in children: Circumstances and diagnostic strategy

International journal of pediatric otorhinolaryngology, 2014-10, Vol.78 (10), p.1632-1636

2014

Link zum Volltext

Verfügbarkeit prüfen

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148)

Vaccine, 2011-06, Vol.29 (25), p.4285-4292

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand

Journal of neuroimmunology, 2008-03, Vol.195 (1), p.100-107

2008

Link zum Volltext

Verfügbarkeit prüfen

Uncertain Futures?

Environment : science and policy for sustainable development, 2006-01, Vol.48 (1), p.39-41

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection

The US Military Commitment to Vaccine Development: A Century of Successes and Challenges

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost

Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors

Lymphoproliferative responses to HIV-1 Gag p24 antigen and mitogens in HIV-1 subtype CRF01_AE infected Thai patients and HIV-1 seronegative donors

Changes in HIV prevalence among young thai men as defined by hepatitis C co-infection as a marker for mode of transmission

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV

Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

Pseudohypacusis in children: Circumstances and diagnostic strategy

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148)

Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand

Uncertain Futures?

Aktive Filter

Suchergebnisse filtern